Pulmonx Corporation balance sheet LUNG

Annual Quarterly

As of Sep 30, 2026, Pulmonx Corporation had total assets of $110.2 million and total liabilities of $76.0 million. Total assets were down 20.3% from a year earlier. Stockholders' equity was $34.2 million. It held $52.7 million in cash and investments against $56.4 million of total debt, net debt of $3.8 million. The current ratio, current assets divided by current liabilities, was 4.05.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

FY 2026
Sep 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Assets
Cash
53
-31.2%
70
-1.6%
71
-15.1%
84
-17.9%
102
-31.5%
148
-35.9%
232
Short-term investments
—
—
—
—
39
+24.8%
32
0
Long-term investments
—
—
—
—
6
-45.9%
11
—
Cash and investments
53
-31.2%
70
-1.6%
71
-15.1%
84
-43.2%
147
-23.0%
191
-17.5%
232
Receivables
12
-12.9%
12
-8.0%
13
+8.4%
12
+39.5%
9
+32.2%
7
+55.2%
4
Inventory
15
-5.0%
16
-6.3%
17
+1.0%
17
+15.0%
15
-10.6%
16
+51.6%
11
Total current assets
84
-24.4%
102
-25.4%
136
-9.4%
150
-11.0%
169
-18.8%
208
-16.8%
250
Property and equipment, net
2
-27.9%
2
-23.6%
3
-27.8%
4
-14.2%
5
-2.5%
5
+226.6%
1
Goodwill
2
+0.0%
2
+0.0%
2
+0.0%
2
+0.0%
2
+0.0%
2
+0.0%
2
Total assets
110
-20.3%
129
-20.6%
163
-8.4%
178
-8.2%
194
-17.6%
235
-10.8%
264
Liabilities and equity
Accounts payable
5
-29.7%
4
+2.0%
4
+155.6%
1
-14.8%
2
+11.1%
2
+7.5%
1
Total current liabilities
21
-9.3%
20
-17.9%
24
+5.5%
23
+25.2%
18
+5.4%
18
+40.1%
13
Total liabilities
76
-2.9%
75
-2.4%
77
+29.6%
59
+49.9%
40
-5.4%
42
+11.6%
38
Stockholders' equity
34
-43.0%
54
-36.9%
86
-27.5%
118
-23.2%
154
-20.3%
193
-14.5%
226
Debt
Debt due within a year
0
-4.8%
0
-96.7%
6
+47.4%
4
-75.1%
17
-0.5%
17
+0.3%
17
Long-term debt
38
+1.9%
37
+8.8%
34
-3.1%
35
—
—
—
Lease liabilities
19
-4.6%
19
-0.1%
19
+361.6%
4
-40.9%
7
-21.7%
9
-8.2%
10
Total debt
56
-0.4%
56
-5.3%
60
+36.9%
44
+78.6%
24
-7.8%
26
-2.8%
27
Net cash
-4
-118.9%
13
+18.0%
11
-71.8%
40
-67.4%
123
-25.4%
165
-19.5%
204
Ratios
Current ratio
4.05x
5.07x
5.58x
6.50x
9.14x
11.85x
19.96x
Debt to equity
1.65x
1.04x
0.70x
0.37x
0.16x
0.14x
0.12x
Return on equity
-124.42%
-99.79%
-65.72%
-51.42%
-38.26%
-25.18%
-14.25%
Return on assets
-38.61%
-41.77%
-34.63%
-34.22%
-30.42%
-20.69%
-12.22%
Book value per share
0.79
1.30
2.16
3.07
4.10
5.23
6.34
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. The first column is the latest balance sheet when it is newer than the latest fiscal year. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
LUNG (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Redwood City, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1127537
Former names
PULMONX (until Feb 7, 2012)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.